StockNews.com downgraded shares of Genesco (NYSE:GCO – Free Report) from a buy rating to a hold rating in a research note issued to investors on Thursday morning.
Genesco Price Performance
Shares of Genesco stock opened at $34.62 on Thursday. The company has a current ratio of 1.53, a quick ratio of 0.40 and a debt-to-equity ratio of 0.15. The firm has a fifty day simple moving average of $28.57 and a 200-day simple moving average of $27.68. The stock has a market capitalization of $388.44 million, a price-to-earnings ratio of -494.50 and a beta of 2.41. Genesco has a 1-year low of $23.21 and a 1-year high of $37.89.
Genesco (NYSE:GCO – Get Free Report) last released its quarterly earnings results on Friday, September 6th. The company reported ($0.83) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.12) by $0.29. The company had revenue of $525.19 million during the quarter, compared to analysts’ expectations of $512.19 million. Genesco had a negative net margin of 0.03% and a positive return on equity of 0.49%. On average, sell-side analysts expect that Genesco will post 0.66 earnings per share for the current year.
Institutional Investors Weigh In On Genesco
About Genesco
Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.
See Also
- Five stocks we like better than Genesco
- Want to Profit on the Downtrend? Downtrends, Explained.
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Most Volatile Stocks, What Investors Need to Know
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.